Table 7.
Assessment of differentiation potential.
| Author | Results | Passage number | Method of assessment |
|---|---|---|---|
| Bacigalupo et al. (47) | ND | NR |
|
| Bueno et al. (37) | • No difference in differentiation potential | 3-5 |
|
| Chao et al. (44) | • AA-MSC lower osteogenic potential - less intense von Kossa stain and lower ALP activity - lower Cbfa1 expression • AA-MSC lower adipogenic potential - lower Oil-Red O activity - lower LPL expression |
3 |
|
| Chaturvedi et al. (31) | • AA-MSC lower osteogenic potential - less alizarin red staining • AA-MSC higher adipogenic potential - higher density and larger size of lipid droplets/vesicles |
3 |
|
| Cheng et al. (35) | • AA-MSC lower osteogenic potential - less alizarin red staining - ALPL expression decreased to 68% in AA-patients • AA-MSC higher adipogenic potential - higher density and larger size of lipid droplets/vesicles - Higher PPARγ expression |
3 |
|
| El-Mahgoub et al. (38) | • AA-MSC lower osteogenic potential - less mineralization and von-Kossa staining • AA-MSC lower adipogenic potential - less lipid-containing cells and smaller size of lipid droplets |
3 |
|
| Huo et al. (29) | • AA-MSC lower chondrogenic potential - less alcian blue staining - lower ACAN and SOX9 expression • AA-MSC lower osteogenic potential - less alizarin red staining - lower RUNX2 and BGLAP expression • AA-MSC higher adipogenic potential - more lipid droplets - higher ADIPOQ and PPARγ expression |
3 |
|
| Jiang et al. (39) | ND | NR |
|
| Li, H. et al. (26) | • AA-MSC lower osteogenic potential - less alizarin red staining - higher DNMT1 expression, lower MEG3 expression, lower BMP4 expression |
3-6 |
|
| Li, H. et al. (27) | • AA-MSC higher adipogenic potential - more lipid droplets - higher miR-146b-5p expression, lower SIAH2 expression, higher PPARγ expression |
3 |
|
| Li, J et al. (42) | • AA-MSC lower osteogenic potential - less von Kossa, alizarin red and alkaline phosphatase activity staining • AA-MSC higher adipogenic potential - more Oil red O staining |
4 |
|
| Li, J et al. (43) | • AA-MSC lower osteogenic potential - less von Kossa, alizarin red and alkaline phosphatase activity staining • AA-MSC higher adipogenic potential - more Oil red O staining |
4 |
|
| Li, S. et al. (28) | • AA-MSC lower osteogenic potential - less alkaline phosphatase activity staining • AA-MSC higher adipogenic potential - more Oil red O staining |
3 |
|
| Michelozzi et al. (33) | • No difference in differentiation potential | 3 |
|
| Sharma et al. (25) |
|
3 |
|
| Shipounova et al. (45) | • AA-MSC lower osteogenic potential - Among patient MSCs that failed osteogenic differentiation, 80% had SAA • AA-MSC lower adipogenic potential - 1 patient without differentiation, 2 patients changed morphology of MSCs without lipid droplet formation, 3 patients with lipid droplet formation without changed morphology |
NR |
|
| Tripathy et al. (40) | • No difference in osteogenic potential • AA-MSC higher adipogenic potential - higher density and larger size of lipid droplets/vesicles - higher expression of adiponectin and FABP4 |
3 |
|
| Wei et al. (34) | • AA-MSC higher adipogenic potential - higher density and larger size of lipid droplets/vesicles at every time point of differentiation - higher FABP4, mTOR, PPARγ, S6K1 and p-S6K1 expression at every time point of differentiation - higher p-mTOR expression |
3 |
|
| Xu et al. (46) | • No difference in osteogenic potential • AA-MSC higher adipogenic potential - no difference in Oil red O staining - lower GATA-2 expression - higher PPARγ expression |
3 |
|
| Zhao et al. (41) | • AA-MSC lower osteogenic potential - fewer and smaller mineralized nodes - lower Runx2 expression (P < 0.05) • AA-MSC higher adipogenic potential - more and larger lipid droplets - higher LPL, PPARγ and miR-204 expression |
3 |
|
ND, not determinable; NR, not reported.